Celldex Therapeutics, Inc.

NASDAQ: CLDXHealthcare / Biotechnology / USA
2.57-0.2100-7.55%Vol 187 3641Y Perf -70.00%
Jun 20th, 2019 16:00
BID2.55 ASK2.83
Open2.80 Previous Close2.78
Pre-Market- After-Trading2.57
 - -%  - -%
Target Price
19.00 
Analyst Rating
Strong Buy 1.00
Potencial %
639.30 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★★+ —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)35 
Earnings Rating
Sell
Price Range Ratio 52wk %
1.84 
Earnings Date
14th Aug 2019

Today's Price Range

2.562.82

52wk Range

2.4011.63

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-10.61%
3 Months
-41.96%
6 Months
-19.42%
1 Year
-70.00%
3 Years
-95.80%
5 Years
-98.90%

Name / TickerPriceChg.Chg.%
CLDX2.57-0.2100-7.55
AAPL199.461.59000.80
GOOG1 111.429.09000.82
MSFT136.951.26000.93
XOM76.611.29001.71
WFC45.860.21000.46
JNJ142.211.76001.25
FB189.532.05001.09
GE10.630.29002.80
JPM110.190.28000.25
Earnings HistoryEstimateReportedSurprise %
Q01 2019-1.14-1.130.88
Q04 2018-1.20-0.9520.83
Q03 2018-2.25-1.2046.67
Q02 2018-2.10-1.6521.43
Q01 2018-2.55-2.85-11.76
Q04 2017-3.45-2.5526.09
Q03 2017-3.60-2.1041.67
Q02 2017-0.25-0.238.00
Earnings Per EndEstimateRevision %Trend
6/2019 QR-1.17-3.54Negative
9/2019 QR-1.21-2.54Negative
12/2019 FY-4.80-2.35Negative
12/2020 FY-3.69-2.50Negative
Next Report Date14th Aug 2019
Estimated EPS Next Report-1.17
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume187 364
Shares Outstanding (in ths.)13 769
Trades Count602
Dollar Volume452 101
Avg. Volume422 721
Avg. Weekly Volume163 099
Avg. Monthly Volume326 710
Avg. Quarterly Volume436 961
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Celldex Therapeutics, Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.

CEO: Anthony S. Marucci

Teplephone: +1 908 200-7500

Address: 53 Frontage Road, Hampton 08827, NJ, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

38%63%

Bearish Bullish

50%50%

Bearish Bullish

64%36%

News